Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: A comparison with marrow transplantation

Bone Marrow Transplantation

Volumn 25, Issue , 2000, Pages S6-S8

  Ringden O ^a   Remberger, M ^a   Runde, V ^b   Bornhauser M ^c   Blau, I W ^d   Basara, N ^d   Holig K ^c   Beelen, D W ^b   Hagglund H ^a   Basu, O ^b   Ehninger, G ^c   Fauser, A A ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Department of Haematology ^*  (Germany)

^d BMT Hospital   (Germany)

Author keywords

Bone marrow transplantation; Engraftment; Graftversus host disease; Leukaemia free survival; Peripheral blood stem cell transplantation; Unrelated donors

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEM CELL TRANSPLANTATION; THROMBOCYTE;

ADOLESCENT; ADULT; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; LEUKEMIA; MIDDLE AGED; NEUTROPHILS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033933383     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702343     Document Type: Article

References (14)

1. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
2. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407.
3. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482.
4. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 995-1003.
5. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced haematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
6. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
7. Ringdén O, Remberger M, Runde V et al. Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with marrow transplantation. Blood 1999; 94: 455-464.
8. Ringdén O, Lönnqvist B, Hägglund H et al. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease (letter). Bone Marrow Transplant 1995; 16: 856-857.
9. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukaemia. New Engl J Med 1986; 314: 729-735.
10. Ringdén O, Bäckman L, Lönnqvist B, et al. A randomized trial comparing the use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies. Bone Marrow Transplant 1986; 1: 41-51.
11. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukaemia. Blood 1990; 78: 2120-2130.
12. Ringdén O, Nilsson B. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation 1985; 40: 39-44.
13. Storb R, Prentice RL, Sullivan KM et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anaemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461-466.
14. Scott MA, Gandhi MK, Jestice HK et al A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case-controlled study. Bone Marrow Transplant 1998; 22: 273-276.